Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors

Haiyuan Xu,1,2,* Jinge Shen,3,* Jianxing Xiang,4 Haiyan Li,4 Bing Li,4 Tengfei Zhang,4 Lu Zhang,4 Xinru Mao,4 Hong Jian,5 Yongqian Shu11Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, People’s Republic of China; 2Department of Oncology, Kunshan...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Xu H, Shen J, Xiang J, Li H, Li B, Zhang T, Zhang L, Mao X, Jian H, Shu Y
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Dove Medical Press 2019-07-01
Rangatū:	Cancer Management and Research
Ngā marau:	receptor tyrosine kinase fusions acquired resistance EGFR tyrosine kinase inhibitors lung cancer
Urunga tuihono:	https://www.dovepress.com/characterization-of-acquired-receptor-tyrosine-kinase-fusions-as-mecha-peer-reviewed-article-CMAR
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!